Belgium· BE-AMP-SAM399996-00

Cisatracurium Fresenius Kabi 2 mg/ml

A cisatracurium product containing cisatracurium besilate, registered in Belgium by Fresenius Kabi. The same ATC class is registered in 15 of our 19 countries.

ATC M03AC11

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about cisatracurium besilateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Cisatracurium is registered in 15 of 19 countries.

Countries holding a registration under ATC M03AC11 (cisatracurium), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
8 of them publish a price we can compare per daily dose

Search cisatracurium products by name

Cisatracurium · ATC M03AC11

15 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Cisatracurium Besilate
Manufacturer: Fresenius Kabi
Country: Belgium (BE)
ATC code: M03AC11
ATC class: Cisatracurium
Defined daily dose: 10.5 mg, P
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 2

be_apb
2906071
be_apb
0752519

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

89 interactions on record for cisatracurium.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check cisatracurium against other medicines How interaction checks work

Cisatracurium · interactions on record

89 records

12 severe
44 moderate
4 minor
29 info

Most severe, free to view

NeomycinA07AA01severe
StreptomycinA07AA04severe
Polymyxin BA07AA05severe
ParomomycinA07AA06severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Cisatracurium in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cisatracurium products

Authorised across Europe · EMA

The same active substance is authorised in 24 EEA countries. Names it is sold under:

Austria · Cisatracurium Accordpharma, Cisatracurium Hikma
Cyprus · Cisatracurium Accordpharma, Cisatral
Czechia · Cisatracurium Kabi, Cisatracurium Kalceks
Germany · Cisatracurium Hameln, Cisatracurium Hikma
Denmark · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
Estonia · Cisatracurium Kalceks
Spain · Cisatracurio Accordpharma, Cisatracurio Hikma
Finland · Cisatracurium Accordpharma, Cisatracurium Fresenius Kabi
France · Cisatracurium Accord, Cisatracurium Accordpharma
United Kingdom (Northern Ireland) · Cisatracurium, Cisatracurium Accord Healthcare
Greece · Cisatral
Croatia · Cisatrakurij Accordpharma
Hungary · Cisatracurium Accordpharma, Cisatracurium Kabi
Ireland · Cisatracurium Kalceks, Cisatracurium Noridem Enterprises
Italy · Cisatracurio Hikma, Cisatracurio Kalceks
Lithuania · Cisatracurium Kalceks
Luxembourg · Nimbex
Latvia · Cisatracurium Kalceks
Netherlands · Cisatracurium Accord, Cisatracurium Accordpharma
Norway · Cisatracurium Accordpharma, Cisatracurium Kalceks
Poland · Cisatracurium Accordpharma, Cisatracurium Kabi
Portugal · Cisatracúrio Accord, Cisatracúrio Accordpharma
Romania · Cisatracurium Noridem
Sweden · Cisatracurium Noridem

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/db237acc-a9e4-453a-b300-3e893c72baaf
GET /v1/drugs/db237acc-a9e4-453a-b300-3e893c72baaf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Solution for injection/infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Cisatracurium Fresenius Kabi 2 mg/ml",
  "name_fr": "Cisatracurium Fresenius Kabi 2 mg/ml",
  "name_nl": "Cisatracurium Fresenius Kabi 2 mg/ml",
  "amp_code": "SAM399996-00",
  "strengths": [
    "2.6800",
    "2.0000"
  ],
  "pack_count": 4,
  "substances": [
    "Cisatracurium Besilate",
    "Cisatracurium"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Cisatracurium",
  "authorisation_numbers": [
    "BE399996"
  ]
}

API reference MCP server Plans

See everything about cisatracurium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console